Clinical Trials for Arsenal Biosciences

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Arsenal Biosciences

Clinical Trials (2)

NCT06245915
AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
PHASE1/PHASE2Active, not recruiting
37 participants
Started: Feb 26, 2024 · Completed: Jun 30, 2028
2 conditions1 sponsor9 locations
NCT05617755
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer
PHASE1Active, not recruiting
19 participants
Started: Nov 29, 2022 · Completed: Feb 28, 2027
9 conditions1 sponsor8 locations